Inhibikase Therapeutics Inc (IKT)

05:41 AM

What analysts say about Inhibikase Therapeutics Inc. stockPowerful growth strategies - PrintWeekIndia

05:41 AM

08:30 AM

Inhibikase Therapeutics Inc. Stock Analysis and ForecastHigh-yield trading alerts - Autocar Professional

08:30 AM

Jul 24, 2025

What drives Inhibikase Therapeutics Inc. stock priceConsistently high yield - Autocar Professional

Jul 24, 2025

Jul 24, 2025

How high can Inhibikase Therapeutics Inc. stock price go in 2025Rapid profit acceleration - jammulinksnews.com

Jul 24, 2025

Jul 23, 2025

Is Inhibikase Therapeutics Inc. a good long term investmentPhenomenal investment performance - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Tianci International Inc. stockTriple-digit profit margins - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

How Inhibikase Therapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser

Jul 22, 2025

Jul 22, 2025

What makes Inhibikase Therapeutics Inc. stock price move sharplyVolume Spike Monitors - Newser

Jul 22, 2025

Jul 18, 2025

What risks could impact Inhibikase Therapeutics Inc. stock performance2x Return Forecast - Newser

Jul 18, 2025

Jul 17, 2025

Why Inhibikase Therapeutics Inc. stock attracts strong analyst attentionSmart High Yield Swing Trades - beatles.ru

Jul 17, 2025

Jul 01, 2025

Inhibikase Therapeutics Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 01, 2025

Jun 30, 2025

Inhibikase Therapeutics shareholders elect directors and approve equity plan changes - Investing.com India

Jun 30, 2025

Jun 30, 2025

Inhibikase Therapeutics Soars 6.79% on Russell 2000 Index Addition - AInvest

Jun 30, 2025

Jun 29, 2025

Inhibikase Therapeutics, Inc.(NasdaqCM: IKT) added to Russell 2500 Index - MarketScreener

Jun 29, 2025

Jun 28, 2025

IKT SEC FilingsInhibikase Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025

Jun 25, 2025

Ludwig Enterprises appoints Garth Lees-Rolfe as independent director By Investing.com - Investing.com UK

Jun 25, 2025

Jun 11, 2025

Squarepoint Ops LLC Acquires Shares of 28,411 Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 11, 2025

Jun 10, 2025

Millennium Management LLC Invests $462,000 in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 10, 2025

Jun 03, 2025

Northern Trust Corp Invests $208,000 in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 03, 2025

May 27, 2025

Inhibikase Therapeutics Insider Buyers Pleased With US$788k Return On Investment - simplywall.st

May 27, 2025